|
| [December 11, 2012] |
 |
Research and Markets: Global Cardiovascular Disorders Drug Pipeline Capsule - 2012
DUBLIN --(Business Wire)--
Research and Markets (http://www.researchandmarkets.com/research/37nrmb/global)
has announced the addition of the "Global
Cardiovascular Disorders Drug Pipeline Capsule - 2012" report
to their offering.
Fore Pharma's latest report Global Cardiovascular Disorders Drug
Pipeline Capsule - 2012' provides up-to-date information on key research
and development activities in the global cardiovascular disorders drug
market. It covers active pipeline molecules under development in various
stages of clinical trials, preclnical research, and drug discovery for
Acute Coronary Syndrome, Hypertension, Myocardial Infarction, Pulmonary
Hypertension, Stroke, and Thrombosis.
This report helps executives track their competitor's pipeline
molecules. The information presented in this report can be used for
identifying partners, evaluating business opportunities, formulating
business development strategies, and executing in-licensing and
out-licensing deals.
The report provides information on pipeline molecules by company,
mechanism of action, stage (phase 3 clinical trials, phase 2 clinical
trials, phase 1 clinical trials, preclinical research, and drug
discovery), and geography (North America, Europe, and Asia).
Key Features of the Report:
- Cardiovascular Disorders Drug Pipeline Insights
- Acute Coronary Syndrome Drug Pipeline Insights
- Hypertension Drug Pipeline Insights
- Myocardial Infarction Drug Pipeline Insights
- Pulmonary Hypertension Drug Pipeline Insights
- Stroke Drug Pipeline Insights
- Thrombosis Drug Pipeline Insights
For more information visit http://www.researchandmarkets.com/research/37nrmb/global

[ Back To Technology News's Homepage ]
|